2026-08-10 · SEMAGLUTIDE · TopGLP1Providers Data Desk
The cheapest compounded semaglutide online, in plain words
At the 2026-08-09 capture, the lowest all-in monthly price we had for compounded semaglutide was $133 a month at Oak Longevity — with the significant caveat that Oak does not serve every state (California is excluded). Other August figures: Yucca Health↗ at $146 and OrderlyMeds↗ at $149. Update, November 10, 2026: Eden now lists $99 a month with no membership (read October 15, 2026) and NexLife↗ $109 a month, dose-flat with no membership (read November 20, 2026). On the brand side, Novo Nordisk's NovoCare↗ channel sells Wegovy to cash payers at $349 a month standard, with a $199 introductory rate on the lowest doses.
Released · Last reviewed · how we verify
Semaglutide is the cheaper half of this market, and also the half where the shape of a price varies most. Some programs are dose-flat: NexLife's $109 (read November 20, 2026) and Mochi's $178 (August capture) all-in figures do not move as your dose climbs the 0.25 mg-to-2.4 mg ladder. Others step up with the dose or with time: Henry Meds↗ advertises injections from $149 but its maintenance figure runs $179; Found advertises from $169 and lands at $289 at maintenance; TrimRx↗ moves from $179 to $299. The advertised number and the number you keep paying are frequently $120 apart, which is why every ranking on this site is built on the maintenance basis, not the teaser.
Membership math matters here too. Mochi's $178 is really $99 of medication plus a mandatory $79 membership; the bundle is honest once you add it up, but the ad copy leads with the smaller number. Eden's $198 figure likewise contains a $99 membership. Neither structure is a problem if you want the coaching those memberships include — it is only a problem when the headline price hides the fee.
Two more numbers frame the semaglutide decision in 2026. First, the brand floor: Wegovy at $349 a month from the manufacturer (or $199 for the first two months at starter doses, and the oral Wegovy pill from $149) means the cheapest compounded programs now undercut the approved product by only $203–$216 a month. Second, the regulatory line: since 2025, compounded semaglutide is limited to patient-specific 503A prescriptions with documented clinical need — the same narrowed lane as tirzepatide, covered date-by-date in our regulatory explainer. If the price gap that brought you to compounded semaglutide has shrunk to double digits, it is worth re-running the whole comparison, including against Wegovy itself.
Before paying any program: confirm the all-in price at your dose in writing, the upfront amount billed today, the pharmacy that fills the prescription, the refund terms, and what happens to the price when the dose changes. The price database carries the capture date and source link behind every figure above.
Compounded semaglutide is not FDA-approved. This is pricing journalism, not medical advice.